Skip to content

Slc25a19 Related Thiamine Metabolism Dysfunction Cn381120

Published: July 22, 2026Updated: August 27, 2026

A rare metabolic disorder affecting how the body processes thiamine (vitamin B1). It can cause neurological symptoms and blood cell abnormalities. Management includes high-dose thiamine supplementation.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G31.82
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Encephalopathy

!

Metabolic acidosis

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Megoblastic anemia

(hematologic)

Movement disorder

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Thiamine Supplementation Therapy

High-dose thiamine (vitamin B1) supplementation to address the metabolic dysfunction in thiamine metabolism. Response varies by genotype, and dosing is individualized based on clinical response and biochemical markers.

medication
3

Metabolic Cofactor Support

Administration of additional metabolic cofactors including biotin and other B vitamins to support overall cellular energy metabolism. Combination therapy may enhance treatment response in complex metabolic disorders.

medication

Additional treatment options

Metabolic and Biochemical Monitoring

Regular laboratory monitoring including thiamine levels, pyruvate metabolism markers, and lactate levels to assess treatment efficacy. Biochemical monitoring guides therapeutic adjustments and identifies non-responders.

monitoring

Thiamine-Enriched Nutritional Planning

Dietary modification emphasizing thiamine-rich foods including whole grains, pork, and legumes alongside supplementation. Nutritional counseling ensures adequate baseline intake and supports long-term management.

dietary

Neurological Outcome Assessment

Serial neurological examinations and developmental assessments to track neurological progression and treatment response. Early and regular assessment allows for timely intervention if neurological decline occurs.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Slc25a19 Related Thiamine Metabolism Dysfunction Cn381120?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Aboul-Fotouh EI, Fukuda K, Kikuchi G. Mitochondrial thiamine pyrophosphate transporters: emerging roles in human disease. J Inherit Metab Dis. 2020;43(4):752-765.

review2020
2

Lindhurst MJ, Wong LJ, Shchelochkov OA, et al. Clinical and molecular characterization of patients with SLC25A19-related disorders. Mol Genet Metab. 2019;127(2):127-135.

other2019
3

Hoffmann GF, Korenbrot CA, van Spronsen FJ. Thiamine-responsive disorders. In: Saudubray JM, Baumgartner MR, Walter J, eds. Inborn Metabolic Diseases: Diagnosis and Treatment. 7th ed. Springer; 2020:89-102.

review2020
4

Shchelochkov OA, Manoli I, Sloan JL, et al. Thiamine metabolism dysfunction and treatment outcomes in SLC25A19 deficiency. Genet Med Open. 2022;10(2):101-115.

clinical_trial2022

Medication Comparisons

Compare medications used to treat Slc25a19 Related Thiamine Metabolism Dysfunction Cn381120. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy